Mycoplasma pneumoniae is an important cause of respiratory tract infections in children as
well as adults that can range in severity from mild to life-threatening. Over the past several …

Atypical pathogens are intracellular bacteria causing community-acquired pneumonia (CAP)
in a significant minority of patients. Legionella spp., Chlamydia pneumoniae and psittaci …

Objective Mycoplasma pneumoniae (M. pneumoniae) is an important pathogen of
community acquired pneumonia. With the outbreak of coronavirus disease 2019 (COVID …

Objectives To analyze the molecular and the clinical characteristics of Mycoplasma
pneumoniae (Mp) pneumonia (MPP) and to explore the related factors predicting severe …

Atypical pneumonia encompasses diverse pathogens, such as Chlamydia pneumoniae,
Mycoplasma pneumoniae and Legionella species, which differ from typical bacterial …

Abstract Background In China mainland, most Mycoplasma pneumoniae related studies are
carried out in Bei**g and Shanghai, while rare studies are performed in the other regions. In …

Emergence of macrolide-resistant Mycoplasma pneumoniae (MRMp) challenges empiric
macrolide therapy. Our goal was to determine MRMp rates and define characteristics of …

Background During the coronavirus disease 2019 (COVID-19) pandemic, the infection of
Mycoplasma pneumoniae (MP) decreased significantly. At the beginning of the summer of …

Mycoplasma pneumoniae is a major cause of community-acquired pneumonia. There are
limited data in the United States on the molecular epidemiological characteristics of M …

Background: Mycoplasma pneumoniae (MP) infections occur in regional outbreaks every 3
to 7 years, lasting up to 2 years. Since this fall, there has been a significant rise in MP …